TrialBlood cancer journal2025

Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.

Federico Lussana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.